<i>In vitro</i> and <i>In vivo</i> Anticancer Effects of the Novel Vitamin E Ether Analogue <i>RRR</i> -α-Tocopheryloxybutyl Sulfonic Acid in Prostate Cancer

Abstract

Oral consumption of VEBSA allows a greater anticancer activity compared with VES. Chemoprevention prefers the oral consumption of agents; the advantage of VEBSA over VES to be administrated orally will allow VEBSA to serve as an agent for both preventive and therapeutic purposes for prostate cancer.